(GMAR) First Trust Exchange-Traded - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F4827 • Defined Outcome
GMAR: Stocks, Options, ETFs
The First Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Moderate Buffer ETF - March (GMAR) is designed to provide a buffer against moderate market downturns while participating in potential gains. Under normal market conditions, the fund primarily invests in FLEX® Options linked to the SPDR® S&P 500® ETF Trust (SPY), which tracks the S&P 500 Index. This strategy aims to balance risk and return for investors seeking equity exposure with downside protection. The fund is non-diversified, meaning it can concentrate its investments in a smaller number of securities, which may increase risk.
The funds structure allows it to offer defined outcome exposure to the U.S. equity market. By utilizing FLEX® Options, GMAR seeks to provide a predefined buffer against losses over a specific period, typically the term of the options strategy. This makes it appealing to investors who want to limit potential losses while maintaining upside potential. The ETF is part of a series of funds with varying buffer levels, catering to different risk tolerance levels.
From a technical standpoint, GMAR has shown stable price action, with its 20-day and 50-day moving averages at 38.12 and 37.86, respectively, indicating a modest upward trend. The 200-day moving average at 36.56 suggests longer-term strength. The Average True Range (ATR) of 0.22 reflects low volatility, while the average 20-day volume of 22,289 shares indicates moderate liquidity. The funds last price of 38.08 aligns closely with its short-term moving averages, signaling potential stability in the near term.
Fundamentally, GMAR manages approximately $288.63 million in assets, giving it a solid scale to execute its investment strategy effectively. The funds focus on SPY-linked FLEX® Options ensures tight correlation with the S&P 500, while the buffer feature provides a unique risk management tool for investors. This combination makes GMAR a viable option for those seeking equity exposure with built-in downside protection.
Additional Sources for GMAR ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GMAR ETF Overview
Market Cap in USD | 289m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2023-03-17 |
GMAR ETF Ratings
Growth 5y | 59.0% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -1.36 |
Analysts | - |
Fair Price Momentum | 35.25 USD |
Fair Price DCF | - |
GMAR Dividends
No Dividends PaidGMAR Growth Ratios
Growth Correlation 3m | 25.6% |
Growth Correlation 12m | 95.8% |
Growth Correlation 5y | 98.6% |
CAGR 5y | 11.53% |
CAGR/Max DD 5y | 2.23 |
Sharpe Ratio 12m | 0.92 |
Alpha | 2.01 |
Beta | 0.46 |
Volatility | 17.82% |
Current Volume | 126.2k |
Average Volume 20d | 30.7k |
As of March 16, 2025, the stock is trading at USD 37.07 with a total of 126,221 shares traded.
Over the past week, the price has changed by -1.54%, over one month by -3.26%, over three months by -1.61% and over the past year by +9.19%.
Partly, yes. Based on ValueRay Analyses, First Trust Exchange-Traded (BATS:GMAR) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.97 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GMAR as of March 2025 is 35.25. This means that GMAR is currently overvalued and has a potential downside of -4.91%.
First Trust Exchange-Traded has no consensus analysts rating.
According to ValueRays Forecast Model, GMAR First Trust Exchange-Traded will be worth about 38.9 in March 2026. The stock is currently trading at 37.07. This means that the stock has a potential upside of +4.96%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 38.9 | 5% |